Platelet-Rich Plasma (PRP) Promotes Fetal Mesenchymal Stem/Stromal Cell Migration and Wound Healing Process

Stem Cell Reviews and Reports

Volumn 10, Issue 3, 2014, Pages 417-428

  Roubelakis, Maria G ^a,b   Trohatou, Ourania ^a,b   Roubelakis, Apostolos ^c,d   Mili, Evgenia ^a,e   Kalaitzopoulos, Ioannis ^d   Papazoglou, Georgios ^d   Pappa, alliopi I ^a   Anagnou, Nicholas P ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

AF MSCs; Cell migration; Healing; PRP

Indexed keywords

PROTEOME;

ADULT; AGED; AMNION FLUID; BIOLOGICAL DRESSING; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; FEMALE; FIBROBLAST; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; SKIN ULCER; THROMBOCYTE RICH PLASMA; VERY ELDERLY; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; AMNIOTIC FLUID; BIOLOGICAL DRESSINGS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PLATELET-RICH PLASMA; PROTEOME; SKIN; SKIN ULCER; WOUND HEALING;

EID: 84899943823     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-013-9494-8     Document Type: Article

References (61)

1. Abdulrazzak, H., Moschidou, D., Jones, G., & Guillot, P. V. (2010). Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. Journal of the Royal Society Interface, 7(Suppl 6), S689-706.
2. Abiko, Y., Arai, J., Matsuzawa, K., Inoue, T., Shimono, M., & Kaku, T. (1996). Human gingival fibroblast migration promoted by platelet-derived growth factor on titanium is correlated with release of urokinase type plasminogen activator. The Bulletin of Tokyo Dental College, 37, 113-118.
3. Amable, P. R., Carias, R. B., Teixeira, M. V., da Cruz Pacheco, I., Correa do Amaral, R. J., Granjeiro, J. M., & Borojevic, R. (2013). Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Research & Therapy, 4, 67.
4. Anitua, E., Muruzabal, F., Alcalde, I., Merayo-Lloves, J. & Orive, G. (2013) Plasma Rich in Growth Factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. Exp Eye Res.
5. Bitsika, V., Roubelakis, M. G., Zagoura, D., Trohatou, O., Makridakis, M., Pappa, K. I., Marini, F. C., Vlahou, A. & Anagnou, N. P. (2011) Human Amniotic Fluid-Derived Mesenchymal Stem Cells As Therapeutic Vehicles: A Novel Approach For the Treatment of Bladder Cancer. Stem Cells Dev.
6. Bitsika, V., Vlahou, A., & Roubelakis, M. G. (2013). Fetal mesenchymal stem cells in cancer therapy. Current Stem Cell Research & Therapy, 8, 133-143.
7. Blume, A., Berger, M., Benie, A. J., Peters, T., & Hinderlich, S. (2008). Characterization of ligand binding to N-acetylglucosamine kinase studied by STD NMR. Biochemistry, 47, 13138-13146.
8. Brem, H., Balledux, J., Bloom, T., Kerstein, M. D., & Hollier, L. (2000). Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Archives of Surgery, 135, 627-634.
9. Bruno, S., Grange, C., Deregibus, M. C., Calogero, R. A., Saviozzi, S., Collino, F., Morando, L., Busca, A., Falda, M., Bussolati, B., Tetta, C., & Camussi, G. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Journal of the American Society of Nephrology, 20, 1053-1067.
10. Campagnoli, C., Bellantuono, I., Kumar, S., Fairbairn, L. J., Roberts, I., & Fisk, N. M. (2002). High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy. BJOG, 109, 952-954.
11. De Coppi, P., Bartsch, G., Jr., Siddiqui, M. M., Xu, T., Santos, C. C., Perin, L., Mostoslavsky, G., Serre, A. C., Snyder, E. Y., Yoo, J. J., Furth, M. E., Soker, S., & Atala, A. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology, 25, 100-106.
12. Delorme, B., Ringe, J., Pontikoglou, C., Gaillard, J., Langonne, A., Sensebe, L., Noel, D., Jorgensen, C., Haupl, T., & Charbord, P. (2009). Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells, 27, 1142-1151.
13. Doucet, C., Ernou, I., Zhang, Y., Llense, J. R., Begot, L., Holy, X., & Lataillade, J. J. (2005). Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. Journal of Cellular Physiology, 205, 228-236.
14. Driver, V. R., Hanft, J., Fylling, C. P., & Beriou, J. M. (2006). A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy/Wound Management, 52, 68-70. 72, 74 passim.
15. Dufour, A., Zucker, S., Sampson, N. S., Kuscu, C., & Cao, J. (2010). Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides. Journal of Biological Chemistry, 285, 35944-35956.
16. English, K., French, A., & Wood, K. J. (2011). Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell, 7, 431-442.
17. Falanga, V. (2005). Wound healing and its impairment in the diabetic foot. Lancet, 366, 1736-1743.
18. Freinkel, R. K., & Woodley, D. T. (2001). The Biology of Skin. New York, London: The Parthenon Publishing Group.
19. Gazouli, M., Roubelakis, M. G., Theodoropoulos, G. E., Papailiou, J., Vaiopoulou, A., Pappa, K. I., Nikiteas, N., & Anagnou, N. P. (2011). OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Molecular Carcinogenesis, 51, 165-173.
20. Hocking, A. M., & Gibran, N. S. (2010). Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Experimental Cell Research, 316, 2213-2219.
21. In't Anker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., Noort, W. A., Claas, F. H., Willemze, R., Fibbe, W. E., & Kanhai, H. H. (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 102, 1548-1549.
22. Javazon, E. H., Keswani, S. G., Badillo, A. T., Crombleholme, T. M., Zoltick, P. W., Radu, A. P., Kozin, E. D., Beggs, K., Malik, A. A., & Flake, A. W. (2007). Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair and Regeneration, 15, 350-359.
23. Kim, J. Y., Song, S. H., Kim, K. L., Ko, J. J., Im, J. E., Yie, S. W., Ahn, Y. K., Kim, D. K., & Suh, W. (2010). Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Cell Transplantation, 19, 1635-1644.
24. Klemmt, P. A., Vafaizadeh, V., & Groner, B. (2011). The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Expert Opinion on Biological Therapy, 11, 1297-1314.
25. Knighton, D. R., Ciresi, K., Fiegel, V. D., Schumerth, S., Butler, E., & Cerra, F. (1990). Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surgery, Gynecology & Obstetrics, 170, 56-60.
26. Kuo, Y. R., Wang, C. T., Cheng, J. T., Wang, F. S., Chiang, Y. C., & Wang, C. J. (2011). Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. Plastic and Reconstructive Surgery, 128, 872-880.
27. Kwon, D. S., Gao, X., Liu, Y. B., Dulchavsky, D. S., Danyluk, A. L., Bansal, M., Chopp, M., McIntosh, K., Arbab, A. S., Dulchavsky, S. A., & Gautam, S. C. (2008). Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. International Wound Journal, 5, 453-463.
28. Lin, C. D., Allori, A. C., Macklin, J. E., Sailon, A. M., Tanaka, R., Levine, J. P., Saadeh, P. B., & Warren, S. M. (2008). Topical lineage-negative progenitor-cell therapy for diabetic wounds. Plastic and Reconstructive Surgery, 122, 1341-1351.
29. Makridakis, M., Gagos, S., Petrolekas, A., Roubelakis, M. G., Bitsika, V., Stravodimos, K., Pavlakis, K., Anagnou, N. P., Coleman, J., & Vlahou, A. (2009). Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer. Proteomics, 9, 287-298.
30. Marrotte, E. J., Chen, D. D., Hakim, J. S., & Chen, A. F. (2010). Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. Journal of Clinical Investigation, 120, 4207-4219.
31. Martin-Rendon, E., Sweeney, D., Lu, F., Girdlestone, J., Navarrete, C., & Watt, S. M. (2008). 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sanguinis, 95, 137-148.
32. Martin, P. (1997). Wound healing-aiming for perfect skin regeneration. Science, 276, 75-81.
33. Martinez-Zapata, M. J., Marti-Carvajal, A., Sola, I., Bolibar, I., Angel Exposito, J., Rodriguez, L., & Garcia, J. (2009). Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion, 49, 44-56.
34. Mazzucco, L., Medici, D., Serra, M., Panizza, R., Rivara, G., Orecchia, S., Libener, R., Cattana, E., Levis, A., Betta, P. G., & Borzini, P. (2004). The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion, 44, 1013-1018.
35. McAleer, J. P., Sharma, S., Kaplan, E. M., & Persich, G. (2006). Use of autologous platelet concentrate in a nonhealing lower extremity wound. Advances in Skin & Wound Care, 19, 354-363.
36. Mirabella, T., Hartinger, J., Lorandi, C., Gentili, C., van Griensven, M., & Cancedda, R. (2012). Proangiogenic soluble factors from amniotic fluid stem cells mediate the recruitment of endothelial progenitors in a model of ischemic fasciocutaneous flap. Stem Cells and Development, 21, 2179-2188.
37. Morigi, M., Rota, C., Montemurro, T., Montelatici, E., Lo Cicero, V., Imberti, B., Abbate, M., Zoja, C., Cassis, P., Longaretti, L., Rebulla, P., Introna, M., Capelli, C., Benigni, A., Remuzzi, G., & Lazzari, L. (2011). Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells, 28, 513-522.
38. Mosna, F., Sensebe, L., & Krampera, M. (2011). Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells and Development, 19, 1449-1470.
39. Murphy, M. B., Blashki, D., Buchanan, R. M., Yazdi, I. K., Ferrari, M., Simmons, P. J., & Tasciotti, E. (2012). Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials, 33, 5308-5316.
40. Prusa, A. R., Marton, E., Rosner, M., Bernaschek, G., & Hengstschlager, M. (2003). Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Human Reproduction, 18, 1489-1493.
41. Roubelakis, M. G. (2013). Therapeutic potential of fetal mesenchymal stem cells. Current Stem Cell Research & Therapy, 8, 115-116.
42. Roubelakis, M. G., Bitsika, V., Zagoura, D., Trohatou, O., Pappa, K. I., Makridakis, M., Antsaklis, A., Vlahou, A., & Anagnou, N. P. (2010). In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. Journal of Cellular and Molecular Medicine, 15, 1896-1913.
43. Roubelakis, M. G., Pappa, K. I., Bitsika, V., Zagoura, D., Vlahou, A., Papadaki, H. A., Antsaklis, A., & Anagnou, N. P. (2007). Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells and Development, 16, 931-952.
44. Roubelakis, M. G., Trohatou, O., & Anagnou, N. P. (2012). Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells International, 2012, 107836.
45. Roubelakis, M. G., Tsaknakis, G., Pappa, K. I., Anagnou, N. P., & Watt, S. M. (2013). Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS One, 8, e54747.
46. Saldalamacchia, G., Lapice, E., Cuomo, V., De Feo, E., D'Agostino, E., Rivellese, A. A., & Vaccaro, O. (2004). A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutrition, Metabolism, and Cardiovascular Diseases, 14, 395-396.
47. Schmidt, B. A., & Horsley, V. (2013). Intradermal adipocytes mediate fibroblast recruitment during skin wound healing. Development, 140, 1517-1527.
48. Singer, A. J., & Clark, R. A. (1999). Cutaneous wound healing. New England Journal of Medicine, 341, 738-746.
49. Trohatou, O., Anagnou, N. P., & Roubelakis, M. G. (2013). Human amniotic fluid stem cells as an attractive tool for clinical applications. Current Stem Cell Research & Therapy, 8, 125-132.
50. Troyer, D. L., & Weiss, M. L. (2008). Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26, 591-599.
51. Tsai, M. S., Hwang, S. M., Tsai, Y. L., Cheng, F. C., Lee, J. L., & Chang, Y. J. (2006). Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biology of Reproduction, 74, 545-551.
52. Tsai, M. S., Lee, J. L., Chang, Y. J., & Hwang, S. M. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction, 19, 1450-1456.
53. Tzeng, Y. S., Deng, S. C., Wang, C. H., Tsai, J. C., Chen, T. M., & Burnouf, T. (2013). Treatment of nonhealing diabetic lower extremity ulcers with skin graft and autologous platelet gel: a case series. BioMed Research International, 2013, 837620.
54. van den Dolder, J., Mooren, R., Vloon, A. P., Stoelinga, P. J., & Jansen, J. A. (2006). Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Engineering, 12, 3067-3073.
55. Volarevic, V., Arsenijevic, N., Lukic, M. L., & Stojkovic, M. (2011). Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells, 29, 5-10.
56. Wang, L., Zhang, Z. G., Zhang, R. L., Gregg, S. R., Hozeska-Solgot, A., LeTourneau, Y., Wang, Y., & Chopp, M. (2006). Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. Journal of Neuroscience, 26, 5996-6003.
57. Wu, Y., Chen, L., Scott, P. G., & Tredget, E. E. (2007). Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells, 25, 2648-2659.
58. Yoon, B. S., Moon, J. H., Jun, E. K., Kim, J., Maeng, I., Kim, J. S., Lee, J. H., Baik, C. S., Kim, A., Cho, K. S., Lee, H. H., Whang, K. Y., & You, S. (2010). Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells and Development, 19, 887-902.
59. Zagoura, D. S., Roubelakis, M. G., Bitsika, V., Trohatou, O., Pappa, K. I., Kapelouzou, A., Antsaklis, A. & Anagnou, N. P. (2011) Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut.
60. Zagoura, D. S., Trohatou, O., Bitsika, V., Makridakis, M., Pappa, K. I., Vlahou, A., Roubelakis, M. G., & Anagnou, N. P. (2013). AF-MSCs fate can be regulated by culture conditions. Cell Death and Disease, 4, e571.
61. Zhou, B., Tsaknakis, G., Coldwell, K. E., Khoo, C. P., Roubelakis, M. G., Chang, C. H., Pepperell, E., & Watt, S. M. (2012). A novel function for the haemopoietic supportive murine bone marrow MS-5 mesenchymal stromal cell line in promoting human vasculogenesis and angiogenesis. British Journal of Haematology, 157, 299-311.